Eye Bright Medical Technology Co., Ltd., established in 2010 in Beijing, China, specializes in crafting a diverse array of ophthalmic medical solutions. The company's extensive product line is geared towards addressing various ocular conditions and visual impairments, encompassing surgical implants, specialized instruments, and diagnostic equipment, as well as optometric lenses and pharmaceutical eye drops. These innovations are developed to provide treatment for a range of eye diseases, notably cataracts, glaucoma, and refractive errors, among other ophthalmic issues.
Subscribe to see Eyebright Medical Technology (Beijing) Co., Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Eyebright Medical Technology (Beijing) Co., Ltd. is a medical devices company headquartered in Beijing, China. It is publicly listed (688050) with a market capitalisation of $1.2B. Xcout tracks 1 named person at Eyebright Medical Technology (Beijing) Co., Ltd., including Robert M. Kershner (M.D., M.S., F.A.C.S.).
A few of Eyebright Medical Technology (Beijing) Co., Ltd.'s closest competitors — see the full list of competitors and alternatives →
Lepu Medical Technology (Beijing) Co., Ltd. operates a cardiovascular health industry platform that provides medical devices, pharmaceutical products, medical services, and health management solutions. The company serves patients, hospitals, and healthcare professionals by offering products such as coronary stents, diagnostic test kits, cardiac pacemakers, and pharmaceuticals, alongside AI-powered electrocardiogram diagnostics and mobile medical services.
Lepu Medical Technology develops and manufactures a wide range of medical devices, equipment, and pharmaceuticals for global healthcare providers and patients. Its product portfolio includes cardiovascular and peripheral interventional products, in vitro diagnostics, structural heart disease solutions, critical care products, hemodyalisis consumables, patient monitors, and orthopedic and surgical implants.
Eximore is a biopharmaceutical platform company headquartered in Israel that is focused on designing innovative solutions for the ophthalmological community. The company develops revolutionary integrated therapeutic delivery systems to address complex eye care needs.
Medimaging Integrated Solution Inc. specializes in delivering advanced digital and mobile diagnostic technology. The company engineers and produces a variety of digital handheld diagnostic scopes, alongside their essential auxiliary equipment. A key product line is the Horus scope system, which encompasses optical coherence tomography (OCT) capabilities, integrated control units, specialized software, and a full suite of accessories. Beyond hardware, Medimaging leverages artificial intelligence for screening applications, notably in detecting diabetic retinopathy, managing wound care, and supporting general medical diagnosis. They also provide comprehensive endoscopy solutions, utilizing advanced micro camera modules to ensure superior visualization and facilitate patient-focused care. These high-performance micro camera modules are also available as standalone components. Established in 2010, Medimaging Integrated Solution Inc. maintains its headquarters in Hsinchu City, Taiwan.
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
OK Biotech Co., Ltd., established in 2006 and based in Hsinchu City, Taiwan, is a global producer and vendor of blood glucose meters. Its product line further encompasses nebulizers, glucometers, blood sugar meters, blood glucose test strips, and personal sound amplifiers.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.